RhumbLine Advisers’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $979K | Buy |
|
|||||
|
2023
Q2 | $405K | Buy |
|
|||||
|
2023
Q1 | $459K | Buy |
|
|||||
|
2022
Q4 | $409K | Buy |
|
|||||
|
2022
Q3 | $439K | Buy |
|
|||||
|
2022
Q2 | $406K | Buy |
|
|||||
|
2022
Q1 | $459K | Sell |
|
|||||
|
2021
Q4 | $522K | Sell |
|
|||||
|
2021
Q3 | $480K | Buy |
|
|||||
|
2021
Q2 | $626K | Buy |
|
|||||
|
2021
Q1 | $712K | Sell |
|
|||||
|
2020
Q4 | $793K | Buy |
|
|||||
|
2020
Q3 | $1.3M | Sell |
|
|||||
|
2020
Q2 | $1.97M | Buy |
|
|||||
|
2020
Q1 | $2.29M | Buy |
|
|||||
|
2019
Q4 | $4.44M | Buy |
|
|||||
|
2019
Q3 | $2.17M | Sell |
|
|||||
|
2019
Q2 | $2.61M | Buy |
|
|||||
|
2019
Q1 | $3.23M | Sell |
|
|||||
|
2018
Q4 | $2.94M | Buy |
|
|||||
|
2018
Q3 | $2.48M | Sell |
|
|||||
|
2018
Q2 | $1.77M | Buy |
|
|||||
|
2018
Q1 | $1.17M | Sell |
|
|||||
|
2017
Q4 | $1.14M | Sell |
|
|||||
|
2017
Q3 | $1.16M | Sell |
|
|||||
|
2017
Q2 | $2.45M | Buy |
|
|||||
|
2017
Q1 | $2.21M | Sell |
|
|||||
|
2016
Q4 | $2.13M | Buy |
|
|||||
|
2016
Q3 | $2.97M | Buy |
|
|||||
|
2016
Q2 | $2.47M | Buy |
|
|||||
|
2016
Q1 | $2.01M | Sell |
|
|||||
|
2015
Q4 | $2.37M | Buy |
|
|||||
|
2015
Q3 | $2.61M | Buy |
|
|||||
|
2015
Q2 | $3.66M | Buy |
|
|||||
|
2015
Q1 | $3.08M | Buy |
|
|||||
|
2014
Q4 | $1.59M | Sell |
|
|||||
|
2014
Q3 | $2.8M | Buy |
|
|||||
|
2014
Q2 | $2.34M | Buy |
|
|||||
|
2014
Q1 | $2.33M | Buy |
|
|||||
|
2013
Q4 | $435K | Buy |
|
|||||
|
2013
Q3 | $399K | Buy |
|
|||||
|
2013
Q2 | $255K | Buy |
|